Healthcare Sector

MRK

Market Tracker

$114.63
+0.43
(+0.38%)
11:00 am
Next Earnings: (est.) 08/01/23 12:00 am
  • MRK (Selected)

    Merck & Co., Inc.
  • MRK#

    Merck & Co., Inc. (MRK
  • MRKR

    Marker Therapeutics, Inc.

MRK Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

MRK Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

MRK Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

MRK Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

MRK Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

MRK Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.04% 77.07M 8.28B
Vanguard 500 Index Fund 2.31% 58.61M 6.3B
Fidelity 500 Index Fund 1.09% 27.79M 2.99B
SPDR S&P 500 ETF Trust 1.08% 27.45M 2.95B
iShares Core S&P 500 ETF 0.89% 22.63M 2.43B
Vanguard Index-Value Index Fund 0.86% 21.91M 2.35B
Select Sector SPDR Fund-Health Care 0.81% 20.59M 2.21B
Vanguard Specialized-Health Care Fund 0.72% 18.31M 1.97B
Vanguard Institutional Index Fund-Institutional Index Fund 0.70% 17.77M 1.91B
Schwab Strategic Tr-Schwab U.S. Dividend Equity ETF 0.68% 17.38M 1.87B

MRK News

  • ELISpot & FluoroSpot Assay Market Report 2026-2031: Mabtech, Oxford Immunotec Global, and Cellular Technology Dominate the Landscape

    03/20 07:00 am

    GlobeNewswire Inc.

    Read more
  • Pfizer vs Moderna: Which Pharma Stock Has More Upside?

    03/19 03:30 pm

    The Motley Fool

    Read more
  • Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics

    03/16 07:00 am

    GlobeNewswire Inc.

    Read more
  • Zostavax Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

    03/09 10:59 am

    GlobeNewswire Inc.

    Read more
  • Rotateq Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

    03/09 10:54 am

    GlobeNewswire Inc.

    Read more
  • 1 Dividend Stock to Buy Hand Over Fist and 1 to Avoid

    03/08 01:30 pm

    The Motley Fool

    Read more
  • Cytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market

    03/05 05:44 am

    GlobeNewswire Inc.

    Read more
  • AI-Powered Tempus Inks New Multi-Year Merck Deal

    03/03 03:33 pm

    Benzinga

    Read more
  • MXene Industry Research Report 2026: Market to Grow at a CAGR of 35.6% to 2032, Driven by EV & Charging Infrastructure, Water Treatment Applications and High-Performance Aerospace & Defense Systems

    03/03 05:53 am

    GlobeNewswire Inc.

    Read more
  • Antibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence

    03/02 05:59 am

    GlobeNewswire Inc.

    Read more
  • 3 Reasons Exelixis Stock Could Deliver Market‑Beating Returns Over the Next Decade

    02/28 05:37 am

    The Motley Fool

    Read more
  • A Symbol of Crisis: As Colorectal Cancer Deaths Rise, Fight CRC Installs United in Blue on the National Mall

    02/27 03:52 pm

    GlobeNewswire Inc.

    Read more
  • 1 Reason I'd Buy Veeva Systems Stock and Never Sell

    02/23 05:37 pm

    The Motley Fool

    Read more
  • Merck's Strategic Shift Signals New Growth Horizons

    02/23 10:16 am

    Benzinga

    Read more
  • Merck Discloses Positive Data For Respiratory Syncytial Virus Antibody Treatment, Seeks FDA Nod For Broader Child Use

    02/19 08:56 am

    Benzinga

    Read more
  • Merck Inks AI Drug Discovery Deal With Mayo Clinic To Revolutionize Drug Discovery

    02/18 02:05 pm

    Benzinga

    Read more
  • FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer

    02/18 11:10 am

    Benzinga

    Read more
  • 2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off

    02/14 09:15 am

    The Motley Fool

    Read more
  • Did Eli Lilly Just Make a Deal for Its Next Blockbuster Drug?

    02/13 11:15 am

    The Motley Fool

    Read more
  • 2 Undervalued Blue Chip Stocks to Buy as the Dow Tops 50,000 Milestone

    02/11 03:35 pm

    Investing.com

    Read more
  • Merck's Keytruda Gets New FDA Approval For Expanded Use In Pretreated Ovarian Cancer Patients

    02/11 11:26 am

    Benzinga

    Read more
  • Should You Buy Moderna Before Feb. 13?

    02/10 12:15 am

    The Motley Fool

    Read more
  • Stock Market Today, Feb. 9: Oracle Climbs on AI Optimism Despite Software Sector Weakness

    02/09 06:02 pm

    The Motley Fool

    Read more
  • 3 Top Dow Jones Dividend Stocks to Buy for Passive Income in 2026

    02/08 10:25 am

    The Motley Fool

    Read more
  • Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC

    02/06 09:00 am

    GlobeNewswire Inc.

    Read more
  • Anti-Obesity Drugs Market to Reach US$195.99 Billion by 2036 as GLP-1 Therapies Drive a Structural Shift in Weight Management

    02/06 06:00 am

    GlobeNewswire Inc.

    Read more
  • Human Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider

    02/05 04:57 am

    GlobeNewswire Inc.

    Read more
  • Merck's Annual Outlook Falls Short But Keytruda, Animal Health Segments Grow

    02/03 12:06 pm

    Benzinga

    Read more
  • Dynavax President and COO Sells 114,000 Shares on Sanofi Acquisition News

    01/30 10:33 am

    The Motley Fool

    Read more
  • FDA Accepts Summit's Lung Cancer Drug Application, Review Underway

    01/29 01:28 pm

    Benzinga

    Read more
  • 2 Pharmaceutical Stocks Set to Rebound in 2026

    01/27 11:17 am

    The Motley Fool

    Read more
  • Why Revolution Medicines Stock Plummeted by Almost 17% Today

    01/26 08:16 pm

    The Motley Fool

    Read more
  • Why Is Cancer Drug Developer Erasca Stock Trading Lower Monday?

    01/26 08:52 am

    Benzinga

    Read more
  • Revolution Medicines Stock Sinks After Merck Deal Talks Collapse

    01/26 07:01 am

    Benzinga

    Read more
  • 1 ETF Could Turn $500 Monthly Into a $800,000 Portfolio That Pays $24,000 in Annual Dividend Income

    01/24 08:30 pm

    The Motley Fool

    Read more
  • 2 Dirt Cheap Stocks to Buy With $200 Right Now

    01/24 10:01 am

    The Motley Fool

    Read more
  • Lipid Nanoparticle Manufacturing Market: An 18.9% CAGR Market Driven by Nucleic Acid Therapies

    01/23 11:00 am

    GlobeNewswire Inc.

    Read more
  • Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million

    01/22 03:02 pm

    Benzinga

    Read more
  • FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer

    01/22 01:51 pm

    Benzinga

    Read more
  • Postpartum Depression Drugs Market Size to Surpass USD 1.97 Billion by 2033, Due to Increasing Awareness & Fast Development of Pharmaceuticals – SNS Insider

    01/22 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Rise As BEA Pegs Q3 GDP At 4.4%— Microsoft, Moderna, Intel In Focus (UPDATED)

    01/22 09:46 am

    Benzinga

    Read more
  • Moderna Stock Rallies as Oncology Results Improve the Platform’s Value Case

    01/21 03:38 pm

    Investing.com

    Read more
  • High Potency APIs Market Size to Reach USD 58.68 Billion by 2033, Driven by the Increasing Demand for Targeted and Oncology Therapies – SNS Insider

    01/21 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Johnson & Johnson Clears the Patent Cliff as 2026 Guidance Resets the Narrative

    01/21 10:43 am

    Investing.com

    Read more
  • Moderna–Merck Cancer Vaccine Shows Durable Benefit At 5 Years In High-Risk Melanoma

    01/20 05:21 pm

    Benzinga

    Read more
  • Sun Pharma Eyes Organon In What Could Be India Pharma's Biggest Cross-Border Deal: Report

    01/20 11:31 am

    Benzinga

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: